Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 907915, 8 pages
http://dx.doi.org/10.1155/2014/907915
Research Article

Adalimumab Ameliorates Abdominal Aorta Cross Clamping Which Induced Liver Injury in Rats

1Department of Internal Medicine, School of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Turkey
2Department of Biochemistry, School of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Turkey
3Department of Histology and Embryology, School of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Turkey
4Department of Surgery, School of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Turkey
5Department of Gastroenterology, School of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Turkey

Received 20 October 2013; Revised 9 December 2013; Accepted 15 December 2013; Published 16 January 2014

Academic Editor: Engin Erturk

Copyright © 2014 Erkan Cure et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Zhang, H. Fu, H. Zhang et al., “Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition,” PLoS ONE, vol. 8, no. 9, Article ID 74422, 2013. View at Google Scholar
  2. E. Ö. Oyar, I. Kiriş, Ş. Gülmen et al., “Adrenomedullin attenuates aortic cross-clampinginduced myocardial injury in rats,” The American Journal of Surgery, vol. 201, no. 2, pp. 226–232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Li, F. X. Zhu, H. B. Zhang, H. Li, and Y. Z. An, “Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice,” Chinese Medical Journal, vol. 126, no. 10, pp. 1855–1859, 2013. View at Google Scholar
  4. M. Trocha, A. Merwid-Ląd, T. Sozański et al., “Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion,” Pharmacological Reports, vol. 65, no. 1, pp. 122–133, 2013. View at Google Scholar
  5. L. Kuo and T. W. Hein, “Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase,” Frontiers in Immunology, vol. 4, p. 237, 2013. View at Google Scholar
  6. N. Thengchaisri, T. W. Hein, W. Wang et al., “Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 2035–2042, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Hoffmann, J. Zweigner, S. H. Smith et al., “Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide,” Infection and Immunity, vol. 74, no. 9, pp. 5058–5066, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Tabuchi, T. Gotoh, K. Miyanaka, K. Tomita, and M. Mori, “Regulation of genes for inducible nitric oxide synthase and urea cycle enzymes in rat liver in endotoxin shock,” Biochemical and Biophysical Research Communications, vol. 268, no. 1, pp. 221–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Chu, A. J. Hickey, A. R. Phillips, and A. S. Bartlett, “The impact of hepatic steatosis on hepatic ischemia-reperfusion injury in experimental studies: a systematic review,” BioMed Research International, vol. 2013, Article ID 192029, 12 pages, 2013. View at Publisher · View at Google Scholar
  10. J. Yang, H. Sun, P. Takacs et al., “The effect of octreotide on hepatic ischemia-reperfusion injury in a rabbit model,” Transplantation Proceedings, vol. 45, no. 6, pp. 2433–2438, 2013. View at Google Scholar
  11. R. F. Schwabe and D. A. Brenner, “Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 4, pp. G583–G589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. F. Schwabe and D. A. Brenner, “Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 283, no. 1, pp. G204–G211, 2002. View at Google Scholar · View at Scopus
  13. Y. Li, R. F. Schwabe, T. DeVries-Seimon et al., “Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-α and interleukin-6: model of NF-κB- and map kinase-dependent inflammation in advanced atherosclerosis,” The Journal of Biological Chemistry, vol. 280, no. 23, pp. 21763–21772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Feng, Q. Wang, H. Wang, and W. Guan, “Tumor necrosis factor-alpha preconditioning attenuates liver ischemia/reperfusion injury through preserving sarco/endoplasmic reticulum calcium-ATPase function,” Journal of Surgical Research, vol. 184, no. 2, pp. 1109–1113, 2013. View at Google Scholar
  15. A. Pergel, M. Kanter, A. F. Yucel, I. Aydin, M. Erboga, and A. Guzel, “Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury,” Toxicology and Industrial Health, vol. 28, no. 10, pp. 923–932, 2012. View at Google Scholar
  16. C. B. Burness and G. M. Keating, “Adalimumab: a review of its use in the treatment of patients with ulcerative colitis,” BioDrugs, vol. 27, no. 3, pp. 247–262, 2013. View at Google Scholar
  17. A. Guzel, M. Kanter, A. Guzel, A. Pergel, and M. Erboga, “Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusion,” Journal of Molecular Histology, vol. 43, no. 3, pp. 361–369, 2012. View at Google Scholar
  18. M. F. Mahmoud, S. M. El Shazly, and W. Barakat, “Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 385, no. 5, pp. 465–471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Yilmaz, S. Tekekoglu, O. Herek, O. Ozmen, Ş. Sahinduran, and T. Buyukoglu, “Ameliorative effect of adalimumab on experimentally induced acute pancreatitis in rats,” Pancreas, vol. 39, no. 8, pp. 1238–1242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Ö. Oyar, I. Kiriş, Ş. Gülmen et al., “The protective effect of adrenomedullin on renal injury, in a model of abdominal aorta cross-clamping,” Thoracic and Cardiovascular Surgeon, vol. 60, no. 1, pp. 5–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kuboki, T. Shin, N. Huber et al., “Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice,” Hepatology, vol. 48, no. 4, pp. 1213–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. V. G. Lee, M. L. Johnson, J. Baust, V. E. Laubach, S. C. Watkins, and T. R. Billiar, “The roles of iNOS in liver ischemia-reperfusion injury,” Shock, vol. 16, no. 5, pp. 355–360, 2001. View at Google Scholar · View at Scopus
  23. T. P. Theruvath, Z. Zhong, R. T. Currin, V. K. Ramshesh, and J. J. Lemasters, “Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: role of vasodilatory and innate immunity pathways,” Transplantation Proceedings, vol. 38, no. 10, pp. 3351–3357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. I. N. Hines, S. Kawachi, H. Harada et al., “Role of nitric oxide in liver ischemia and reperfusion injury,” Molecular and Cellular Biochemistry, vol. 234-235, no. 1-2, pp. 229–237, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Dai, Z. Wu, Y. Yang et al., “Nitric oxide and energy metabolism in mammals,” Biofactors, vol. 39, no. 4, pp. 383–391, 2013. View at Google Scholar
  26. F. N. Salloum, A. Das, A. Samidurai et al., “Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 6, pp. H1347–H1354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Tratsiakovich, A. T. Gonon, A. Krook et al., “Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels,” European Journal of Pharmacology, vol. 712, no. 1–3, pp. 16–21, 2013. View at Google Scholar
  28. J. Grönros, A. Kiss, M. Palmér, C. Jung, D. Berkowitz, and J. Pernow, “Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model,” Acta Physiologica, vol. 208, no. 2, pp. 172–179, 2013. View at Google Scholar
  29. C. M. Lin, J. F. Lee, L. L. Chiang, C. F. Chen, D. Wang, and C. L. Su, “The protective effect of curcumin on ischemia-reperfusion-induced liver injury,” Transplantation Proceedings, vol. 44, no. 4, pp. 974–947, 2012. View at Google Scholar
  30. R. Kireev, S. Bitoun, S. Cuesta et al., “Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis,” European Journal of Pharmacology, vol. 701, no. 1–3, pp. 185–193, 2013. View at Google Scholar
  31. Y. Cai, Y.-X. Cao, S.-M. Lu, C.-B. Xu, and L. O. Cardell, “Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats,” International Immunology, vol. 23, no. 7, pp. 443–451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Takagi, T. Yonezawa, S. Haga et al., “Changes of activity and mRNA expression of urea cycle enzymes in the liver of developing Holstein calves,” Journal of Animal Science, vol. 86, no. 7, pp. 1526–1532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. L. R. Aristoteles, R. F. Righetti, N. M. Pinheiro et al., “Modulation of the oscillatory mechanics of lung tissue and the oxidative stress response induced by arginase inhibition in a chronic allergic inflammation model,” BMC Pulmonary Medicine, vol. 13, p. 52, 2013. View at Google Scholar
  34. H. Liu, H. Dong, K. Robertson, and C. Liu, “DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma,” American Journal of Pathology, vol. 178, no. 2, pp. 652–661, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. K. Mistry, Z. Greenfeld, S. M. Morris Jr., and C. Baylis, “The “intestinal-renal” arginine biosynthetic axis in the aging rat,” Mechanisms of Ageing and Development, vol. 123, no. 8, pp. 1159–1165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Sankaralingam, H. Xu, and S. T. Davidge, “Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia,” Cardiovascular Research, vol. 85, no. 1, pp. 194–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Romero, D. H. Platt, H. E. Tawfik et al., “Diabetes-induced coronary vascular dysfunction involves increased arginase activity,” Circulation Research, vol. 102, no. 1, pp. 95–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Modolell, I. M. Corraliza, F. Link, G. Soler, and K. Eichmann, “Reciprocal regulation of the nitric oxide synthase-arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines,” European Journal of Immunology, vol. 25, no. 4, pp. 1101–1104, 1995. View at Google Scholar · View at Scopus
  39. H. Fang, A. Liu, U. Dahmen, and O. Dirsch, “Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase,” Cell Death & Disease, vol. 4, p. e694, 2013. View at Google Scholar
  40. M. Elias-Miro, M. B. Jimenez-Castro, J. Rodes, and C. Peralta, “Current knowledge on oxidative stress in hepatic ischemia/reperfusion,” Free Radical Research, vol. 47, no. 8, pp. 555–568, 2013. View at Google Scholar
  41. M. Feng, Q. Wang, H. Wang, and W. Guan, “Tumor necrosis factor-alpha preconditioning attenuates liver ischemia/reperfusion injury through preserving sarco/endoplasmic reticulum calcium-ATPase function,” Journal of Surgical Research, vol. 184, no. 2, pp. 1109–1113, 2013. View at Google Scholar
  42. R. di Paola, T. Genovese, D. Impellizzeri, A. Ahmad, S. Cuzzocrea, and E. Esposito, “The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1: a comparison with infliximab treatment,” European Journal of Pharmacology, vol. 700, no. 1–3, pp. 134–146, 2013. View at Google Scholar
  43. C. Tasdemir, S. Tasdemir, N. Vardi et al., “Protective effect of infliximab on ischemia/reperfusion-induced damage in rat kidney,” Renal Failure, vol. 34, no. 9, pp. 1144–1149, 2012. View at Publisher · View at Google Scholar
  44. D. Pathirana, A. D. Ormerod, P. Saiag et al., “European S3-Guidelines on the systemic treatment of psoriasis vulgaris,” Journal of the European Academy of Dermatology and Venereology, vol. 24, no. 1, pp. 117–118, 2010. View at Google Scholar